Kazuya Sakai1, Masataka Kuwana2, Hiroto Kojima3, Hidenori Tanaka3, Masanori Matsumoto1 (1.Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan, 2.Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, 3.HLA Foundation Laboratory, Kyoto, Japan)
Session information
Oral Session
Oral Session 3-13C TMA and Others
Sun. Oct 13, 2019 2:30 PM - 3:30 PM No.13 (Tokyo International Forum, 6F G602)
Chair: Masanori Matsumoto (Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan)
Yuta Kimura1, Tomomi Ito1, Junichi Watanabe1, Ken Naganuma1, Yuka Tanaka1, Yasuyuki Takahashi1, Tatsuki Tomikawa1, Tomoe Anan1, Morihiko Sagawa1, Yoko Yoshida2, Yuka Sugawara2, Yoichiro Ikeda2, Takayuki Tabayashi1, Reiko Nakaseko1, Michihide Tokuhira1, Masahiro Kizaki1 (1.Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan, 2.Division of Nephrology and Endocrinology, The University of Tokyo, Japan)
Noriaki Kawano1, Naoko Ikeda1, Tomohiro Abe2, Takashi Nakaike1, Taro Tochigi1, Kiyoshi Yamashita1 (1.Department of Internal medicine, Miyazaki Prefectural Miyazaki Hospital, 2.Department of Emergency, Miyazaki Prefectural Miyazaki Hospital)
Toshiki Yamada1, Hisashi Tsurumi2 (1.Dept. Hematol., Gifu Pref. General Medical Center, Gifu, Japan, 2.Dept. Hematol., Matsunami General Hosp, Gifu, Japan)
Fumitaka Shibasaki1, Masahiro Takeyama2, Keiji Nogami2, Kana Sasai2, Midori Shima2 (1.Nara Medical University, Kashihara, Japan, 2.Department of Pediatrics, Nara Medical University, Kashihara, Japan)
Takashi Satoh1,2, Hayato Takiguchi2, Haruki Uojima3, Hisashi Hidaka3, Makoto Kubo4, Koji Miyazaki5, Ryouichi Horie1,2 (1.Division of Hematology, Kitasato Univ., Kanagawa, Japan, 2.Division of Molecular Hematology, Kitasato Univ., Kanagawa, Japan, 3.Department of Gastroenterology, Kitasato Univ., Kanagawa, Japan, 4.Division of Immunology, Kitasato Univ., Kanagawa, Japan, 5.Department of Transfusion and Cell Transplantation, Kitasato Univ., Kanagawa, Japan)